You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Booster dose Moderna and Pfizer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Moderna COVID-19 Bivalent Booster for Omicron BA.4/5

Recruiting
  • COVID-19
  • Moderna COVID-19 Vaccine
  • +3 more
  • Culver City, California
    Science37
Mar 9, 2023

COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)

Not yet recruiting
  • COVID-19
  • Pfizer-BioNTech Standard dose
  • +5 more
  • Bandung, West Java, Indonesia
  • +2 more
Nov 30, 2022

COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)

Active, not recruiting
  • COVID-19
  • Tozinameran - Standard dose
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital
Aug 24, 2022

COVID-19 Vaccines Trial in Paris (2nd booster with Comirnaty® (Pfizer-BioNTech), CoV2 preS dTM adjuvanted vaccine (B.1.351),

Active, not recruiting
  • COVID-19 Vaccines
  • 2nd booster with Comirnaty® (Pfizer-BioNTech)
  • CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK
  • Paris, France
    GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022

COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

Not yet recruiting
  • COVID-19
  • Tozinameran
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022

SARS CoV 2 Infection, COVID-19 Trial in Brownsville, Edinburg, Rio Grande City (Pfizer/BioNTech (BNT162b2), Moderna)

Recruiting
  • SARS CoV 2 Infection
  • COVID-19
  • Pfizer/BioNTech (BNT162b2)
  • Moderna
  • Brownsville, Texas
  • +3 more
Mar 14, 2022

COVID-19 Breakthrough Infection in Fully Vaccinated People and

Enrolling by invitation
  • COVID-19 Pneumonia
  • COVID-19
  • Pfizer COVID-19 mRNA vaccine
  • Moderna COVID-19 mRNA vaccine
  • Dallas, Texas
    Methodist Dallas Medical Center
May 24, 2022

COVID-19, Vaccine Reaction, COVID-19 Pandemic Trial in San Francisco (Moderna Booster Vaccine, Pfizer Booster Vaccine)

Enrolling by invitation
  • COVID-19
  • +2 more
  • Moderna Booster Vaccine
  • Pfizer Booster Vaccine
  • San Francisco, California
    UCSF Parnassus
Mar 1, 2022

Lung Transplant Recipient, SARS-CoV-2, Immunosuppression Trial (mRNA-1273 (Moderna COVID-19 vaccine))

Active, not recruiting
  • Lung Transplant Recipient
  • +2 more
  • mRNA-1273 (Moderna COVID-19 vaccine)
  • Los Angeles, California
    UCLA Clinical Translational Research Center
Dec 13, 2022

Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single

Not yet recruiting
  • Safety of a Single Dose of COMVIGEN Vaccine
  • +5 more
  • Comvigen (Bivalent, ChulaCov19 BNA159.2)
  • BIVALENT Pfizer/BNT vaccine
  • Bangkok, Thailand
  • +1 more
Jun 29, 2023

COVID-19 Trial in Melbourne (Bivalent Moderna, Novavax)

Not yet recruiting
  • COVID-19
  • Bivalent Moderna
  • Novavax
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Jan 23, 2023

Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

Recruiting
  • Multiple Myeloma
  • +2 more
  • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 12, 2022

Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,

Active, not recruiting
  • Immunogenicity
  • +2 more
  • SW-BIC-213;SARS-Cov-2.
  • +2 more
  • Savannakhét, Sava, Lao People's Democratic Republic
    Savannakhét Provincial hospital
Jan 8, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

Booster Dose of Comirnaty in Children Ages 6 Months Though 4

Not yet recruiting
  • SARS-CoV-2
  • COVID-19
  • COMIRNATY intramuscular injection
  • Tokyo, Japan
    Pfizer Local Country
Nov 8, 2023

Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,

Recruiting
  • Kidney Transplant Recipients
  • Liver Transplant Recipients
  • Pfizer-BioNTech Bivalent COVID-19 Vaccine
  • +3 more
  • San Diego, California
  • +14 more
Oct 31, 2022

COVID-19 Trial in Natal, São Paulo (SCB-2019/Clover, AstraZeneca/Fiocruz, Pfizer/Wyeth)

Active, not recruiting
  • COVID-19
  • SCB-2019/Clover
  • +2 more
  • Natal, Rio Grande Do Norte, Brazil
  • +1 more
Apr 10, 2023

COVID-19, Vaccine Reaction Trial in Paris (BNT162b2, CoV2 preS dTM adjuvanted vaccine (D614), Sanofi/GSK, CoV2 preS dTM

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • BNT162b2
  • +2 more
  • Paris, France
    GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 7, 2022

Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,

Recruiting
  • COVID-19
  • ChAdOx1 nCOV-19 vaccine (Vaxzeria)
  • +3 more
  • São Paulo, Brazil
    Techtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023

COVID-19, SARS CoV 2 Infection Trial in Australia (ChulaCov19 BNA159 vaccine (50 mcg), Pfizer/BNT vaccine (30 mcg))

Not yet recruiting
  • COVID-19, SARS CoV 2 Infection
  • ChulaCov19 BNA159 vaccine (50 mcg)
  • Pfizer/BNT vaccine (30 mcg)
  • Bruce, Australian Capital Territory, Australia
  • +4 more
Nov 15, 2022

Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose Trial in Paris

Active, not recruiting
  • Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
  • Pfizer
  • Moderna
  • Paris, France
    CIC 1417 Cochin-Pasteur
Jul 31, 2021

Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)

Active, not recruiting
  • Chronic Kidney Diseases
  • COVID-19
  • Pfizer-BioNTech COVID-19 Vaccine
  • MODERNA SARS-CoV-2 Vaccine
  • Scarborough, Ontario, Canada
  • +2 more
Aug 5, 2022

Kidney Transplant Recipients Trial in Baltimore (mRNA-1273 vaccine (Pfizer/BioNTech), mRNA-1273 vaccine (Moderna))

Active, not recruiting
  • Kidney Transplant Recipients
  • mRNA-1273 vaccine (Pfizer/BioNTech)
  • mRNA-1273 vaccine (Moderna)
  • Baltimore, Maryland
    Johns Hopkins Hospital
Oct 4, 2021

COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Spain (COVID-19 Vaccine HIPRA, Cominarty (Pfizer-BioNtech))

Recruiting
  • COVID-19
  • SARS-CoV-2 Acute Respiratory Disease
  • COVID-19 Vaccine HIPRA
  • Cominarty (Pfizer-BioNtech)
  • Badalona, Barcelona, Spain
  • +9 more
Sep 27, 2022